{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:09:05Z","timestamp":1771420145023,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ensci.2025.100599","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:49:45Z","timestamp":1764262185000},"page":"100599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between DATSCAN-derived dopaminergic activity and cognitive performance and quality of life in Parkinson's disease: A cross-sectional study"],"prefix":"10.1016","volume":"42","author":[{"given":"Farzaneh","family":"Ramezani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SeyedAli","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faezeh","family":"Safari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ensci.2025.100599_bb0005","author":"World Health Organization"},{"issue":"4","key":"10.1016\/j.ensci.2025.100599_bb0010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ensci.2025.100599_bb0015","first-page":"1","article-title":"Oxidative stress and Parkinson\u2019s disease: pathophysiology and therapeutic perspectives","volume":"132","author":"Blesa","year":"2015","journal-title":"Prog. Neurobiol."},{"issue":"11","key":"10.1016\/j.ensci.2025.100599_bb0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.ensci.2025.100599_bb0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"2007","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.ensci.2025.100599_bb0030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1474-4422(13)70123-6","article-title":"Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson\u2019s disease","volume":"12","author":"Petzinger","year":"2013","journal-title":"Lancet Neurol."},{"issue":"13","key":"10.1016\/j.ensci.2025.100599_bb0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study","volume":"72","author":"Aarsland","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ensci.2025.100599_bb0040","first-page":"1523","article-title":"The Parkinson\u2019s disease questionnaire (PDQ-39): development and validation","volume":"26","author":"Jenkinson","year":"2017","journal-title":"Qual. Life Res."},{"issue":"3","key":"10.1016\/j.ensci.2025.100599_bb0045","first-page":"587","article-title":"DAT imaging in Parkinson\u2019s disease: clinical and research perspectives","volume":"265","author":"Moll","year":"2018","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.ensci.2025.100599_bb0050","first-page":"987","article-title":"Dopamine transporter imaging in Parkinson\u2019s disease","volume":"6","author":"Booij","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ensci.2025.100599_bb0055","first-page":"95","article-title":"Functional imaging of the dopaminergic system in PD and drug response","volume":"5","author":"Leenders","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2025.100599_bb0060","first-page":"1481","article-title":"DAT imaging and cognitive performance in Parkinson\u2019s disease: a review","volume":"29","author":"Vriend","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2025.100599_bb0065","first-page":"2556","article-title":"Dopaminergic imaging and non-motor symptoms in PD","volume":"128","author":"Hilker","year":"2005","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ensci.2025.100599_bb0070","first-page":"168","article-title":"Dopamine transporter imaging in Parkinson\u2019s disease: applications and limitations","volume":"29","author":"Narayanan","year":"2014","journal-title":"Mov. Disord."},{"issue":"Pt 7","key":"10.1016\/j.ensci.2025.100599_bb0075","first-page":"1810","article-title":"Dopaminergic contribution to motor dysfunction in Parkinson\u2019s disease: insights from neuroimaging","volume":"132","author":"Vaillancourt","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ensci.2025.100599_bb0080","first-page":"1","article-title":"Pathophysiology of neuropsychiatric symptoms in Parkinson\u2019s disease","volume":"128","author":"Becker","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.ensci.2025.100599_bb0085","first-page":"421","article-title":"Functional imaging in Parkinson\u2019s disease: dopaminergic and non-dopaminergic contributions","volume":"26","author":"Br\u00fccke","year":"2013","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.ensci.2025.100599_bib147","first-page":"953","article-title":"Neuropathology of non-motor symptoms of Parkinson\u2019s disease","volume":"119","author":"Jellinger","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ensci.2025.100599_bb0090","first-page":"147","article-title":"Cognitive dysfunction in Parkinson\u2019s disease: mechanisms and management","volume":"7","author":"McKinley","year":"2012","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.ensci.2025.100599_bb0095","first-page":"159","article-title":"The concept of mild cognitive impairment in Parkinson\u2019s disease","volume":"14","author":"Mahlknecht","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.ensci.2025.100599_bb0100","first-page":"241","article-title":"Advanced statistical modeling in Parkinson\u2019s disease research: handling missing data and outliers","volume":"7","author":"Foster","year":"2017","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.ensci.2025.100599_bb0105","first-page":"45","article-title":"Statistical considerations in Parkinson\u2019s disease research: outlier and imputation effects","volume":"4","author":"Vasilenko","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ensci.2025.100599_bb0110","series-title":"Parkinson\u2019s Disease and Movement Disorders","author":"Jankovic","year":"2015"},{"issue":"12","key":"10.1016\/j.ensci.2025.100599_bb0115","first-page":"1430","article-title":"Imaging of dopaminergic neurons in Parkinson\u2019s disease: current and future perspectives","volume":"27","author":"Antonini","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2025.100599_bb0120","first-page":"1010","article-title":"Personalized medicine in Parkinson\u2019s disease: neuroimaging and clinical integration","volume":"10","author":"Kemp","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ensci.2025.100599_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.ensci.2025.100599_bb0130","first-page":"294","article-title":"Neurobiology and treatment of Parkinson\u2019s disease","volume":"34","author":"Schapira","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.ensci.2025.100599_bb0135","first-page":"2381","article-title":"Functional connectivity and cognitive impairment in Parkinson\u2019s disease: an fMRI study","volume":"33","author":"Kim","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.ensci.2025.100599_bb0140","first-page":"3","article-title":"Neuroimaging in Parkinson\u2019s disease: bridging dopamine loss and cognitive decline","volume":"15","author":"M\u00fcller","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240565022500053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240565022500053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:31:13Z","timestamp":1771417873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240565022500053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S240565022500053X"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2025.100599","relation":{},"ISSN":["2405-6502"],"issn-type":[{"value":"2405-6502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between DATSCAN-derived dopaminergic activity and cognitive performance and quality of life in Parkinson's disease: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2025.100599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100599"}}